We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-11.81%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73M
AUM Growth
-$5.17B
Cap. Flow
-$776M
Cap. Flow %
-13,535.32%
Top 10 Hldgs %
49.82%
Holding
217
New
75
Increased
44
Reduced
24
Closed
41

Sector Composition

Rank Sector Weight
1 Healthcare 44.4%
2 Consumer Staples 8.91%
3 Consumer Discretionary 7.35%
4 Technology 4.07%
5 Communication Services 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPB icon
201
Spectrum Brands
SPB
$2.06B
-120,000
Closed -$10.6M
SPY icon
202
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$801B
-24,000
Closed -$1.08B
TELA icon
203
TELA Bio
TELA
$32.2M
-192,000
Closed -$2.23M
TGT icon
204
Target
TGT
$67.8B
-321,698
Closed -$68.3M
TPR icon
205
Tapestry
TPR
$31.5B
-77,594
Closed -$2.88M
TTNP
206
DELISTED
Titan Pharmaceuticals
TTNP
-43,176
Closed -$826K
USAU icon
207
US Gold Corp
USAU
$218M
-408,627
Closed -$2.86M
PIXY
208
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
-79
Closed -$2.22M
PHXM
209
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
-194,408
Closed -$3.4M
SIEN
210
DELISTED
Sientra, Inc.
SIEN
-120,000
Closed -$2.66M
MARK
211
DELISTED
Remark Holdings, Inc.
MARK
-423,729
Closed -$3.47M
KDNY
212
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-756,000
Closed -$12.4M
AGRX
213
DELISTED
Agile Therapeutics
AGRX
-2,274
Closed -$953K
CYRN
214
DELISTED
CYREN Ltd.
CYRN
-27,615
Closed -$139K
HTGM
215
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
-69,505
Closed -$1.16M
OCDX
216
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
-3,324,000
Closed -$62M
BHVN
217
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-524,000
Closed -$62.1M

Similar funds

Armistice Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Armistice Capital held 217 positions worth $5.73M, down 100% from $5.17B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $776M in Q2 2022, closing 41 positions and reducing 24 holdings. Its most notable exit was Home Depot, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in O'Reilly Automotive worth $92K.

  • Armistice Capital's largest Q2 2022 buy was O'Reilly Automotive: 2,183,715 shares worth $92K.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2022, an estimated $67.6M increase.
  • Armistice Capital's biggest Q2 2022 reduction was Biogen, cutting an estimated $68.7M.
  • Armistice Capital fully exited Home Depot in Q2 2022, selling an estimated $105M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.73M portfolio in Q2 2022.
  • Armistice Capital opened 75 new positions and closed 41 in Q2 2022.
  • Armistice Capital's portfolio value fell 100% quarter-over-quarter to $5.73M.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.